α-secretase and β-secretase are known to compete for amyloid precursor protein (APP) processing and thus play a vital role in Alzheimer's disease pathogenesis. A disintegrin and metalloproteinase 10 (ADAM10) and β-site APP cleaving enzyme 1 (BACE1) mediate the major activities of α-secretase and β-secretase in brain and share various common substrates. However, whether they function separately or together is poorly understood. Here, we show that ADAM10 and BACE1 co-localize in the neurites of mouse primary neurons. Co-immunoprecipitation and fluorescence resonance energy transfer analysis revealed that ADAM10 and BACE1 interact with each other under both endogenous and exogenous conditions. In addition, we found that ADAM10 enhances the proteolysis of neural cell adhesion molecule close homolog of L1 (CHL1) by BACE1. Further studies found that ADAM10-BACE1 interaction interfering peptide LT52 attenuates the regulation of ADAM10 on BACE1-mediated cleavage of CHL1. Our data indicate that ADAM10-BACE1 interaction regulates the proteolysis of some specific substrates and may play a potential role in brain function.
Introduction
The prevailing amyloid hypothesis suggests that amyloid β peptide (Aβ) accumulation and deposition trigger a sequence of pathological changes that ultimately lead to Alzheimer's disease (AD) (Hardy and Selkoe, 2002) . Secretases have been identified to be potential therapeutic targets for AD due to their vital roles in Aβ generation (De Strooper et al., 2010) . Previous reports showed that presenilin 1 (PS1), the catalytic subunit of γ-secretase, interacts with β-secretase BACE1 (Hebert et al., 2003; Kuzuya et al., 2007) and the interaction interfering compound reduces Aβ production . Besides, Chen et al. (2015) confirmed the interaction between α-secretase and γ-secretase and proposed a new model in which the two secretases may physically interrelate and form a complex capable of sequential processing. It is well known that α-secretase and β-secretase compete for amyloid precursor protein (APP) ectodomain shedding (Skovronsky et al., 2000; Colombo et al., 2013) and are crucial to the initiation of Aβ production. However, whether they function separately or together is poorly understood.
Recently, various neuronal glycoproteins have been reported to be the sharing substrates of a disintegrin and metalloproteinase 10 (ADAM10) and β-site APP cleaving enzyme 1 (BACE1) (Kuhn et al., 2012 (Kuhn et al., , 2016 , two proteases that have been identified to be the major α-and β-secretase in neurons, respectively (Lammich et al., 1999; Vassar et al., 1999; Kuhn et al., 2010) . However, it remains elusive that whether ADAM10 and BACE1 were in close proximity or even interact with each other in the regulation of substrates processing. Among these substrates, the neural cell adhesion molecule close homolog of L1 (CHL1) was shown to promote neurite outgrowth, axon guidance, and neuronal survival (Chen et al., 1999; Hillenbrand et al., 1999; Hitt et al., 2012; Barão et al., 2015) . Besides, it was revealed that ADAM10 and BACE1 activities affect CHL1 ectodomain cleavage and its cellular level in neurons and in vivo (Kuhn et al., 2016) . Although the molecular insight of CHL1 cleavage by BACE1 was validated (Zhou et al., 2012) , the manner in which ADAM10 affects CHL1 proteolysis remains unclear (Naus et al., 2004) . Moreover, little is known about whether ADAM10 and BACE1 interact with each other and whether the interaction plays a role on CHL1 and other sharing substrates processing. In this study, we report that ADAM10 and BACE1 co-localize in mouse primary neurons and interact under both endogenous and exogenous conditions. We also found that ADAM10 enhances BACE1-mediated CHL1 proteolysis. In addition, we identified BACE1 N-terminal peptide LT52 competes for the interaction between ADAM10 and BACE1 and attenuates the regulation of ADAM10 on BACE1-mediated cleavage of CHL1.
Results

ADAM10 interacts with BACE1 in mouse brain and primary neurons
ADAM10 and BACE1 have been shown to be enriched in different subcellular compartments from mouse or rat brain tissues using biochemical fractionation approaches (Marcello et al., 2007; Lundgren et al., 2015) . In order to explore whether ADAM10 and BACE1 interact with each other under endogenous conditions, we performed co-immunoprecipitation assay in mouse brains. Microsomes prepared from postnatal (P1) mouse brain tissue were solubilized in 1% CHAPSO-contained IP buffer, and then immunoprecipitated with ADAM10 antibody or control IgG. As shown in Figure 1A , BACE1 was detected in the ADAM10-immunopurified complex, but not in the control IgG group. Besides, no co-immunoprecipitation was observed between ADAM10 and fibroblast growth factor receptor 1 (FGFR1), indicating a specific interaction between endogenous ADAM10 and BACE1 in mouse brain.
Further, we sought to investigate the interaction between ADAM10 and BACE1 in neural cells. First, we applied immunofluorescent staining to investigate the localization of endogenous ADAM10 and BACE1 in mouse primary neurons. Primary neurons were obtained from P1 mice and stained at 3-7 days in vitro (DIV3-DIV7) when axons and dendrites could be clearly distinguished (Beaudoin et al., 2012) . As shown in Supplementary Figure S1 , ADAM10 and BACE1 both co-localized with the axonal marker Tau and the dendritic marker MAP2, consistent with the previous studies about their functions in axons and dendrites (Kandalepas et al., 2013; Marcello et al., 2013; Buggia-Prévot et al., 2014; Romi et al., 2014) . Then we examined whether ADAM10 and BACE1 co-localize. We labeled endogenous ADAM10 and BACE1 in primary neurons and observed that ADAM10 colocalized with BACE1 in both axons ( Figure 1B ) and dendrites ( Figure 1C) . As ADAM10 and BACE1 were also reported to be expressed in astrocytes (Rossner et al., 2001; Kieseier et al., 2003) , we also labeled both secretases in mouse primary astrocytes, but little co-localization was observed throughout the cells ( Figure 1D ). As quantified in Figure 1E , the percentage of ADAM10 or BACE1 co-localized in the regions of interest (ROI) and Pearson's coefficient in ROI volume were significantly higher in axons or dendrites than those in astrocytes, suggesting that ADAM10 might colocalize with BACE1 in the neurites of primary neurons.
To validate whether the co-localization of ADAM10 and BACE1 in neurons suggests a potential interaction, we performed fluorescence resonance energy transfer (FRET) assay. The energy transfer takes place only when the donor and the acceptor are in close proximity of no more than 10 nm, which is in accordance with biomolecular interaction distance (Llères et al., 2007) . ADAM10 and BACE1 in mouse primary neurons were labeled with Alex488 or Cy3 fluorophore, between which the energy transfer was reported (Wahlster et al., 2013) , and then the FRET efficiency of co-localized areas in neurites was measured. We observed that after photobleaching, the fluorescence intensity of Alex488 increased in the photobleached region, but not in the non-photobleached regions ( Figure 1F ), indicating that the energy transfer occurred. On an average, the FRET efficiency between ADAM10 and BACE1 was ∼15%, which was significantly higher than that between BACE1 and MAP2 and was comparable with PS1 internal FRET (between PS1 N-terminal and loop domain) ( Figure 1G ). Together, our data demonstrate that endogenous ADAM10 and BACE1 physiologically interact in mouse brain and primary neurons.
The interaction between ADAM10 and BACE1 could be monitored in cell lines
We further investigated the interaction between ADAM10 and BACE1 in cell lines. ADAM10 and Flag-tagged BACE1 were expressed in HEK 293T cells and the cell lysates containing 1% CHAPSO ( Figure 2A , lanes 1 and 2) or 1% Triton X-100 ( Figure 2A , lanes 3-6) were immunoprecipitated with anti-Flag resin. We found that ADAM10 was detected in immunopurified complex in both conditions ( Figure 2A, lanes 2 and 4) . ADAM10 was also detected in 1% Triton X-100 immunopurified complex washed with 0.3% SDS-contained buffer in which the non-specific interaction should be removed ( Figure 2A , lane 6). Moreover, both immature and mature forms of ADAM10 and BACE1 were observed in the immunopurified complex in these conditions. As an unrelated type I membrane protein, type II TGFβ receptor (TGFβR2) was not detected in the immunopurified complex (Supplementary Figure S2) , indicating that the interaction between ADAM10 and BACE1 detected in HEK 293T cells might be specific.
To confirm the interaction between ADAM10 and BACE1 within cells, we performed FRET assay in HEK 293 cells ( Figure 2B ). First, we examined whether fluorescent protein tagged ADAM10 and BACE1 were enzymatically active. Increased sAPPα or sAPPβ production was observed in HEK 293/APPswe cells when ADAM10-mTurquoise2 or BACE1-mCitrine was expressed, respectively (Supplementary Figure S3) , suggesting that fluorescent protein tagged ADAM10 and BACE1 possessed α-secretase or β-secretase activity. In order to avoid artificial association caused by robust protein levels, ADAM10-mTurquoise2 and BACE1-mCitrine were expressed at near physiological levels ( Figure 2C ). We observed that the FRET efficiency between ADAM10-mTurquoise2 and BACE1-mCitrine was ∼15%, which was significantly higher than the negative control and was comparable with FRET efficiency between mTurquoise2-PS1 and BACE1-mCitrine or that between ADAM10-mTurquoise2 and mCitrine-PS1 ( Figure 2D ). Besides, a significant FRET efficiency between ADAM10-mTurquoise2 and BACE1-mCitrine was also detected in the neuroblastoma cell line SH-SY5Y ( Figure 2E ). , and astrocytes (C). Primary neurons obtained from P1 mice were fixed and stained at DIV3-DIV7 with ADAM10 and BACE1-specific antibodies. White arrows point to co-localization of ADAM10 with BACE1. (E) Quantification of ADAM10 and BACE1 co-localization in primary neuron axons, dendrites, and primary astrocytes. Images were processed and ROIs were analyzed using Imaris software. N = 11, 9, and 9 for neuron axons, dendrites, and astrocytes, respectively. A one-way ANOVA with Bonferroni's multiple comparisons was used. ***P < 0.001, **P < 0.01. (F) Mouse primary neurons were stained for ADAM10 and BACE1 with primary antibodies followed by Cy3-or Alex488-conjugated secondary antibodies, and then analyzed by acceptor photobleaching FRET. Representative images are shown. BP, before photobleaching; AP, after photobleaching. The arrows point at the photobleached area. Scale bar, 10 μm. (G) Quantification of acceptor photobleaching FRET analysis in E. Neurons were stained for BACE1 and MAP2, or PS1 N-terminal and loop domain, and subjected to FRET analysis as controls. N = 34-40 per condition. A one-way ANOVA with Bonferroni's multiple comparisons was used. ***P < 0.001. n.s., no significance.
Together, our data demonstrate that the interaction between ADAM10 and BACE1 could be monitored in cell lines.
Direct interaction between extracellular domains of ADAM10 and BACE1 revealed by bio-layer interferometry
To further explore whether ADAM10 and BACE1 directly interact, we purified the extracellular domains (ECDs) of ADAM10 and BACE1 from Escherichia coli. In an in vitro secretase assay, purified ADAM10-ECD and BACE1-ECD showed α-secretase or β-secretase activity in a dose-dependent manner ( Figure 3A and B). We also observed the inhibitory effects of GI254023X or BSI-IV, the ADAM10 or BACE1 inhibitor, on purified ADAM10-ECD or BACE1-ECD activity ( Figure 3A and B) .
We then used bio-layer interferometry to conduct a kinetic analysis of the interaction between ECDs of ADAM10 and BACE1. First, ADAM10 was biotinylated and immobilized on streptavidin (BACE1-Flag) and ADAM10 in HEK 293T cells. HEK 293T cells overexpressing BACE1-Flag and ADAM10 were lysed in IP buffer containing 1% CHAPSO (lanes 1 and 2) or 1% Triton X-100 (lanes 3-6), and cell extracts were subjected to co-IP assay using anti-Flag resins. The immunoprecipitated complex was washed with IP buffer (lanes 1-4) or 0.3% SDS-containing IP buffer (lanes 5 and 6) before elution. (B) Representative images of ADAM10-mTurquoise2 (ADAM10-Tur)/BACE1-mCitrine (BACE1-Cit) FRET in HEK 293 cells. HEK 293 cells overexpressing ADAM10-Tur and BACE1-Cit were fixed and analyzed by acceptor photobleaching FRET. White boxes indicate the enlarged area. BP, before photobleaching; AP, after photobleaching. The white circles mark the photobleached area. Scale bar, 10 μm. (C) Western blots analysis showed that ADAM10-mTurquoise2 (ADAM10-T) and BACE1-mCitrine (BACE1-C) were expressed at near physiological levels in FRET experiments. The lysate of HEK 293 cells without transfection was used as a control. (D) Quantification of acceptor photobleaching FRET analysis in C. N = 12, 27, 17, and 30 for negative control, BACE1-C/T-PS1, ADAM10-T/C-PS1, and BACE1-C/ADAM10-T, respectively. A one-way ANOVA with Bonferroni's multiple comparisons was used. ***P < 0.001, vs. the negative control. (E) Acceptor photobleaching FRET analysis of ADAM10-Tur/BACE1-Cit in neuroblastoma cell line SH-SY5Y. Cells expressing ADAM10-Tur and Cit (ADAM10-T/C) were used as a negative control. An unpaired two-tailed Student's t-test was used. ***P < 0.001, vs. ADAM10-T/C. biosensors (SAs). The SAs were then incubated in wells containing different concentrations of purified BACE1 (0.125-2 μM). Representative data for association/dissociation phases of the curves are shown in Figure 3C (the experimental data are presented by blue lines and the fitting curves are indicated by red lines). We observed temporary and quick initial association/dissociation steps, followed by much longer and slower steps in the binding curves of ADAM10 with BACE1. We also performed the kinetic analysis using immobilized BACE1 incubated with a series of concentrations of ADAM10. Compared to the signal between immobilized ADAM10 and BACE1, similar binding profile and ∼35% lower maximum response were observed in the binding curves of immobilized BACE1 and ADAM10 ( Figure 3D ).
Global fitting of the experimental data generated a best fit with the 1:1 interaction model. The association/dissociation rate constants (k on and k off ) and affinities (K D ) are presented in Figure 3C and D (right panels), in which the estimated response at equilibrium for each analyte concentration rather than the k on and k off values was used. The single steadystate equilibrium dissociation constants K D and the R max which represents the saturating binding level are presented in Table 1 . Taken together, these results suggest that ADAM10-ECD directly interacts with BACE1-ECD.
BACE1 N-terminal peptide LT52 interferes with the interaction between ADAM10 and BACE1
To explore the potential binding motif in BACE1 with ADAM10, we investigated the tertiary structure of BACE1-ECD, which comprises of an N-lobe and a C-lobe (Supplementary Figure S4A) . First, we evaluated the kinetic properties of the interaction between ADAM10-ECD and the N-lobe or C-lobe of BACE1-ECD. As shown in Supplementary Figure S4B and C, in comparison with BACE1-ECD or the C-lobe, the N-lobe of BACE1-ECD interacted with ADAM10-ECD with ∼30% higher maximum responses (N-lobe vs. C-lobe vs. . α-secretase inhibitor GI254023X (20 μM) and β-secretase inhibitor BSI-IV (10 μM) showed inhibitory effects on ADAM10-ECD or BACE1-ECD activities. *P < 0.05, **P < 0.01, ***P < 0.001 as determined by unpaired two-tailed Student's t-test. (C and D) Bio-layer interferometry analysis of the interaction between ADAM10-ECD and BACE1-ECD using the ForteBio Octet Red instrument. (C) SAs immobilized with 50 μg/ml biotinylated ADAM10-ECD were incubated in wells containing different concentrations of purified BACE1-ECD. (D) BACE1-loaded SAs incubated with a series of concentrations of purified ADAM10 solution were also monitored at 25°C. The 1:1 interaction model was used to fit all the association/dissociation steps. The experimental data are represented by blue lines and the curve fitting data are indicated by red lines. The steady-state analysis of binding data are shown on the right. BACE1-ECD, 0.63 nm vs. 0.41 nm vs. 0.47 nm). Furthermore, reduced maximum response of the interaction between ADAM10-ECD and BACE1-ECD was observed in the presence of the N-lobe of BACE1-ECD (Supplementary Figure S4D) . To further investigate the binding sites, we generated several N-terminal peptides from the N-lobe of BACE1-ECD. Then we performed the bio-layer interferometry assay using immobilized ADAM10-ECD and BACE1 peptides. As shown in Figure 4B , we observed that LT52, an N-terminal peptide from BACE1 (residues 43-94, Figure 4A ) bound to ADAM10-ECD in a dose-dependent manner. In contrast, a scrambled control peptide LT52-S, which has the identical amino acids with LT52 (Supplementary Figure S5A) , showed a much weaker interaction with ADAM10 (Supplementary Figure S5B) . Further, reduced maximum response in the binding curve of BACE1-ECD with ADAM10-ECD was observed in the presence of LT52 ( Figure 4C ), while much lower reduction was observed in the presence of LT52-S (Supplementary Figure S5C) . Thus, our data suggest that the N-lobe of BACE1 might play a role in ADAM10-BACE1 interaction and an interaction interfering peptide LT52 from the N-lobe of BACE1 was identified.
We then examined the effect of LT52 on cellular interaction between ADAM10 and BACE1 by co-IP and FRET assays. Reduced amount of ADAM10 was detected in the immunopurified BACE1-Flag complex in the presence of increased concentrations of BACE1 peptide LT52, but not the control peptide LT52-S ( Figure 4D and E). Similar result was obtained in FRET assay. In HEK 293 cells, LT52 reduced the FRET efficiency between ADAM10 and BACE1, while LT52-S showed little effect ( Figure 4F) . Moreover, we also examined whether LT52 could compete for the interaction between endogenous ADAM10 and BACE1 in mouse primary neurons. We infected neurons with lentivirus expressing GFP, LT52, or LT52-S. Five days later, neurons were fixed and stained for endogenous ADAM10 and BACE1. The FRET measurement was performed by photobleaching the acceptor to a certain extent and then calculating the enhancement of the donor's fluorescence intensity. As shown in Figure 4G and H, LT52 reduced the FRET efficiency between endogenous ADAM10 and BACE1 in a dose-dependent manner, while LT52-S showed little effect. Taken together, these results demonstrate that BACE1 N-terminal peptide LT52 could interfere with the interaction between ADAM10 and BACE1.
LT52 attenuates the ADAM10 regulation on BACE1-mediated cleavage of CHL1
Recent studies have identified some glycoproteins as sharing substrates for ADAM10 and BACE1, suggesting the cross-talk between them (Kuhn et al., 2012 (Kuhn et al., , 2016 ). Thus we hypothesized that the interaction between ADAM10 and BACE1 might modulate the proteolysis of sharing substrates. As ADAM10 and BACE1 are known to compete for APP cleavage, we wondered whether LT52, the ADAM10-BACE1 interaction interfering peptide, could modulate α-cleavage or β-cleavage of APP. To test this, APP peptides that contain α-cleavage or β-cleavage site were used to monitor the ectodomain shedding of APP by ADAM10 or BACE1. Membrane fractions extracted from HEK 293T cells were incubated with APP peptides as previously reported . Whereas a classical α-secretase inhibitor TAPI-1 inhibited α-site cleavage of APP, LT52 expression showed little effect (Supplementary Figure S6A) . BACE1 inhibitor IV significantly inhibited β-site cleavage of APP, while expression of LT52 showed no detectable effect (Supplementary Figure S6B) .
To further explore whether LT52 has an effect on APP processing, we assessed the cleavage pattern of APP in cells. As shown in Supplementary Figure S6C and D, in HEK 293/APPswe cells, expression of ADAM10 increased the production of sAPPα and C83, while the expression of BACE1 enhanced the generation of sAPPβ and C99 and reduced the production of sAPPα and C83 in the meantime. However, the expression of LT52 showed little effect on the proteolysis of APP. Further, we examined the APP cleavage pattern in mouse primary neurons from APP/PS1 transgenic mice. Seven days after infection with lentivirus expressing GFP, LT52, or LT52-S, the culture media and neurons were collected to detect APP cleavage products. As shown in Supplementary Figure S6E -G, BSI-IV treatment reduced the generation of sAPPβ and C99 and increased the production of sAPPα and C83, while LT52 showed little effect on sAPPα, sAPPβ, C83, or C99 generation, in accordance with what was observed in HEK 293/APPswe cells. These data suggest that the ADAM10-BACE1 interaction might not affect APP cleavage.
Previous studies suggest that ADAM10 and BACE1 activities affect the cleavage of neural cell adhesion molecule close homolog of L1 (CHL1) (Kuhn et al., 2016) . It is validated that CHL1 is cleaved by BACE1 in vitro and in vivo (Zhou et al., 2012) . However, whether CHL1 is cleaved by α-secretases remains ambiguous (Naus et al., 2004) . First we investigated the cleavage of CHL1 by BACE1 and ADAM10 in HEK 293T cells. As shown in Figure 5A , when Flag-CHL1-HA was expressed alone, we observed only small amounts of both CHL1 C-terminal fragments (CTFs) in cell lysate and soluble N-terminal fragments (sCHL1) in culture media, implying the limited cleavage of CHL1 by endogenous proteases. When Flag-CHL1-HA was co-expressed with BACE1, we found that the CTF slightly below 25 kDa and the sCHL1 in culture medium augmented dramatically, while the other CTFs reduced simultaneously in accordance with the previous report (Zhou et al., 2012) . Co-expression of ADAM10 with Flag-CHL1-HA also resulted in the increment of CTFs which differed from the fragment produced by BACE1 in molecular weight. Besides, the sCHL1 was also increased, but it was not easy to be distinguished from the fragment produced by BACE1 because of the similar molecular weight. To clarify whether the proteolysis of CHL1 was dependent on BACE1 or ADAM10 activity, we generated the reported inactive mutants, BACE1 D93A or DADA (Ebina et al., 2009 ) and ADAM10 E384A (Lammich et al., 1999) . As shown in Supplementary Figure S7A and B, the inactive mutants could not cleave CHL1. In accordance with this, BACE1 inhibitor IV and α-secretase inhibitor TAPI-1 decreased the proteolysis of CHL1 (Supplementary Figure S7C and D) . Hence, our data suggest that both BACE1 and ADAM10 are responsible for CHL1 shedding in HEK 293T cells.
To explore whether the interaction between ADAM10 and BACE1 participated in CHL1 processing, we expressed Flag-CHL1-HA, ADAM10, and BACE1 in HEK 293T cells. As shown in Figure 5B , we observed that the expression of ADAM10 increased the level of the CHL1 CTF produced by BACE1. In addition, either expression of ADAM10 E384A mutant or treatment with α-secretase inhibitor TAPI-1 increased the CHL1 CTF generated by BACE1 as well ( Figure 5B and C) . Moreover, a comparable interaction of BACE1 with wild-type ADAM10 or the E384A mutant was observed ( Figure 5D ). Besides, TAPI-1 treatment showed no effect on the interaction between ADAM10 and BACE1 ( Figure 5E and F) . Taken together, these data indicate that the facilitation of ADAM10 on BACE1-mediated CHL1 processing might be dependent on the interaction between ADAM10 and BACE1, but not ADAM10 activity. Further, the expression of LT52, but not the control peptide LT52-S, reduced CHL1 CTF generated by BACE1 ( Figure 5G ), suggesting that the ADAM10-BACE1 interaction interfering peptide attenuated the ADAM10 regulation on CHL1 cleavage by BACE1, further supporting the possibility that ADAM10 could regulate CHL1 cleavage via interacting with BACE1.
Discussion
AD-associated secretases (α-secretase, β-secretase, and γ-secretase) play critical roles in regulating various biological processes. Previous studies showed that α-secretase or β-secretase could form larger complex with γ-secretase (Chen et al., 2015; Cui et al., 2015) . Our current study extends the relationship among AD-related secretases by providing evidence that ADAM10 and BACE1 interact with each other. The co-localization between endogenous ADAM10 and BACE1 was observed in primary neurons, and the interaction between them was detected using co-IP and FRET assays under endogenous conditions. Previous report showed that the endocytosis of ADAM10 was clathrin-dependent and the association between ADAM10 and AP2 was required in the process (Marcello et al., 2013) . Although BACE1 internalization was thought to be proceeded mostly via clathrin-independent routes (Sannerud et al., 2011) , AP2 was also reported to interact with BACE1 and mediate BACE1 internalization (Prabhu et al., 2012) . These studies give the possibility that ADAM10 encounters and interacts with BACE1 during subcellular trafficking. So far, the binary interactions among α-secretase, β-secretase, and γ-secretase have been studied, which have also been shown to be associated with the proteolysis of sharing substrates. Further, whether α-secretase, β-secretase, and γ-secretase form a ternary protease complex to facilitate the substrates processing needs to be explored.
Besides, the direct interaction between purified ECDs of ADAM10 and BACE1 was confirmed using bio-layer interferometry. We identified that LT52, an N-terminal peptide from BACE1, competes for the ADAM10-BACE1 interaction both in a purified system and in cells, suggesting that the ectodomains of ADAM10 and BACE1 might be important for their interaction. However, the interaction between ADAM10 and BACE1 were only partially reduced by LT52, especially in cellular assays, possibly because that the existence of mutiple binding sites in BACE1 with ADAM10 makes it difficult to disrupt the interaction effectively. It has also been noticed in the studies about the interactions of other membrane proteins (Liu et al., 2013; Cui et al., 2015) . On the other hand, the possibly insufficient local concentration, uncertain conformation of the peptide, and the limited transfection efficiency may also provide explanations to the partial inhibition.
Beyond the physical interaction between ADAM10 and BACE1, we further investigated the potential function. As the major secretases in brain and drug targets for AD therapeutics (Barão et al., 2015; Macleod et al., 2015) , ADAM10 and BACE1 have been well studied to identify their potential physiological substrates. Many neuronal glycoproteins have been found to be cleaved by both ADAM10 and BACE1, such as APP and CHL1. In our study, we found that ADAM10 increased the cleavage of CHL1 by BACE1, which was attenuated by ADAM10-BACE1 interaction interfering peptide, but not by the inhibition of ADAM10 activity, suggesting an ADAM10-BACE1 interaction-dependent CHL1 proteolysis. However, LT52 showed relatively mild effect on CHL1 proteolysis, probably because of its modest effect on Figure 5 LT52 attenuates the ADAM10 regulation on BACE1-mediated cleavage of CHL1. (A) HEK 293T cells were transfected with designated plasmids and subjected to CHL1 cleavage analysis. The cell lysates and conditioned medium were collected and analyzed by western blots. (B) HEK 293T cells were transfected with Flag-CHL1-HA, BACE1, and ADAM10 or inactive ADAM10 E384A mutant. Western blots showed that ADAM10, as well as ADAM10 mutant E384A, enhanced the production of CHL1 C-terminal fragments (CTF) or soluble N-terminal fragments (sCHL1) produced by BACE1. (C) TAPI-1 showed little effect on ADAM10 modulation on the production of CHL1 CTF and sCHL1 processed by BACE1. HEK 293T cells were transfected with Flag-CHL1-HA, BACE1, and ADAM10. Twenty-four hours after transfection, cells were treated with DMSO or 100 μM α-secretase inhibitor TAPI-1 for 24 h. The cell lysates and conditioned medium were collected and analyzed by western blots. (D) FRET analysis of the interaction between BACE1 and wild-type ADAM10 or inactive E384A mutant in HEK 293 cells. (E and F) FRET measurement (E) and co-immunoprecipitation analysis (F) of the interaction between ADAM10 and BACE1 in the absence or presence of TAPI-1. Cells were treated with DMSO or TAPI-1 (100 μM) for 8 h and collected for FRET measurement or coimmunoprecipitation analysis. (G) Cells overexpressing LT52 showed decreased production of CHL1 CTF and sCHL1 processed by BACE1. HEK 293T cells were transfected with Flag-CHL1-HA, BACE1, ADAM10, and LT52 or LT52-S. the interference with ADAM10-BACE1 interaction. Therefore, the identification of more potent antagonist peptides that could effectively disrupt ADAM10-BACE1 interaction for substrates proteolysis studies will further strengthen our conclusions. On the other hand, our data suggest that only a small portion of ADAM10 and BACE1 interact with each other, and the interaction might play a partial role in the proteolysis of sharing substrates.
In addition, we observed that LT52 showed little effect on APP processing either in membrane fraction extracts or in cells. Although more potent antagonist peptides and more systems should be adopted to confirm this phenomenon, our results indicate the complexity of the cross-talk between ADAM10 and BACE1. According to the previous report, APP accumulated little by either ADAM10 deletion or BACE1 inhibition, while greater accumulation of CHL1 was observed when BACE1 activity was inhibited other than ADAM10 deletion (Kuhn et al., 2016) . These results suggest a possibility that the discrepant degree of cleavage by the two proteases might result in the diverse influences of ADAM10-BACE1 interaction on substrates processing. On the other hand, ADAM10 and BACE1 exert enzyme activities in various cellular compartments (Lammich et al., 1999; Gutwein et al., 2003; Kinoshita et al., 2003) , thus the substrate residence may have an impact on the regulated proteolytic process. Therefore, the subcellular co-localization of ADAM10 and BACE1, as well as the influence of the interaction on other substrate processing need to be further studied.
CHL1 was reported to promote neurite outgrowth and sema3A-induced growth cone collapse in primary neurons and be also involved in axon guidance and dendrite orientation in vivo (Wright et al., 2007; Schlatter et al., 2008) . Recently, the CTF of CHL1 generated by BACE1 was found to be required for semaphorin 3A-induced growth cone collapse in thalamic neurons (Barão et al., 2015) . However, the functions of other proteolytic fragments of CHL1 have not been well studied. It is worth exploring whether ADAM10-BACE1 interaction regulates CHL1 processing in neurons thus plays a role in neurite development.
Materials and methods
Co-immunoprecipitation assay
Brain tissue was obtained from postnatal (P1) mice and homogenized in buffer A (25 mM Tris-HCl, pH 7.4, 5 mM EDTA, 5 mM EGTA) and centrifuged to remove debris and nuclei. The resulting supernatant was centrifuged at 25000 g to collect microsomes which were then solubilized in IP buffer (50 mM HEPES, pH 7.4, 150 mM NaCl, 10% Glycerol, and 1% CHAPSO) for 30 min followed by another 25000 g spin. Protein concentration of soluable microsomes was determined using Pierce BCA Protein Assay Kit (ThermoFisher Scientific) and 1.2 mg of microsomes were incubated with ADAM10 antibody Ab1997 or control rabbit IgG at 4°C for 16 h. The immunoprecipitated complexes were incubated with pre-equilibrated EzviewRed Protein A Affinity Gel beads (Sigma) for 1.5 h at 4°C. After washed, the resins were eluted with 0.1 M glycine buffer followed by SDSpolyacrylamide gel electrophoresis (SDS-PAGE) analysis.
Forty-eight hours after transfection, HEK 293T cells were lysed in 1% CHAPSO-or 1% Triton X-100-contained IP buffer. After centrifugation, the supernatants were incubated with anti-Flag M2 resins at 4°C for 4 h. Immunoprecipitated complexes were washed, eluted, and resolved in SDS-PAGE. ADAM10-BACE1 coIPs interfered by LT52 or LT52-S peptides were quantified using ImageJ software. The ADAM10 immunoblots intensity of IP and input lanes were quantified, respectively, and the co-IP ADAM10 level was analyzed by calculating the IP/Input ratio.
Immunofluorescence staining
Primary neurons at 3-7 days in vitro (DIV3-DIV7) were fixed with PBS/2% paraformaldehyde, permeabilized, and blocked with PBS/0.1% Saponin/2% BSA. Then cells were incubated with primary antibodies at room temperature for 2 h or 4°C overnight. After washed with PBS/0.1% Saponin/2% BSA, cells were incubated with Alex488-, Cy3-, or Alex647-labeled secondary antibodies for 1 h and followed by DAPI staining in the dark at room temperature. Then cells were mounted on slides after washed.
Co-localization analysis
Images were acquired under a confocal microscope (LAS SP8; Leica) with a 63×/1.40 NA oil objective (Leica). Imaging conditions were set up manually: DAPI (excitation: 405 nm, emission: 415-450 nm), Alex488 (excitation: 488 nm, emission: 500-550 nm), Cy3 (excitation: 561 nm, emission: 575-625 nm), and Alex647 (excitation: 633 nm, emission: 650-700 nm). In order to get a more clear and smooth image, line average was set to be 4. The interested regions of neurites were acquired.
Background subtraction and co-localization analysis were performed with Imaris. In general, ROIs were drawn along the axons or dendrites (for neurons), or around the whole cell (for astrocytes). Intensity thresholds were defined in Coloc module for every singular channel to discriminate signals from the background, and the values were set similarly for all images analyzed. The volume pixels with signal intensity above set threshold in both channels were taken as co-localized areas. The percentage of ADAM10 co-localized with BACE1 and the percentage of BACE1 co-localized with ADAM10 in ROIs as well as Pearson's coefficient in these regions were presented.
Acceptor photobleaching FRET measurement
For FRET measurement, cells were grown on glass coverslipscontained plates. Primary neurons were plated and stained as described above. HEK 293 cells and SH-SY5Y cells were transfected with designated plasmids using Effectene Transfection Reagent (QIAGEN, 301427), then fixed in PBS/2% paraformaldehyde 24-48 h post-transfection. After washed with PBS for three times, the cells were mounted on slides for FRET detection.
Samples were then subjected to acceptor photobleaching FRET imaging under a confocal microscope (LAS SP8; Leica) with a 63×/1.40 NA oil objective (Leica) as described previously . Image acquisition, registration, background subtraction, and data analyses were performed with Leica Application Suite Advanced Fluorescence (LAS AF) software. Imaging conditions were set up manually: Alex488, Cy3, and Alex647 as described above, CFP (excitation: 405 nm, emission: 465-505 nm), and YFP (excitation: 514 nm, emission: 525-600 nm). Photobleach was performed using acceptor excitation light and the similar bleach efficiency (∼80%-90%) was achieved. Images of donor and acceptor channels were acquired pre-and post-bleach, respectively. FRET efficiency was calculated as percentage of enhancement in donor fluorescence (f) after acceptor photobleaching: E = 1 − f[CFP(pre)]/f[CFP(post)]. Five non-bleached regions were selected and the average value was used to correct the FRET efficiency of photobleached region.
Bio-layer interferometry assay
Bio-layer interferometry analyses were performed using Octet Red 96 (ForteBio) as described previously (Wang et al., 2016) . The ligands were biotinylated and immobilized on SAs (ForteBio) with typical immobilization levels to be above 3 nm, and then were incubated with different concentrations of analytes in the kinetics buffer. The systematic baseline drifts were corrected by subtracting the shift recorded from a sensor loaded with ligands and incubated with no analytes. All binding experiments were performed in solid-black 96-well plates containing 200 μl of solution in each well at 25°C with an agitation speed of 1000 rpm. Curve fitting, steady-state analysis, and calculation of kinetic (k on , k off , and K D ) and R max parameters were done using Octet software version 7.0 (ForteBio). The goodness of fit for the binding data was assessed by evaluation of the χ 2 and R 2 values generated from all the fitting analysis. All the experiments were repeated at least three times.
Statistical analysis
All experiments were repeated at least three times and data are presented as mean ± SEM and analyzed by GraphPad Prism 6.01. Unpaired Student's t-test was used for the comparisons between two groups. One-way analysis of variance (ANOVA) followed Bonfferoni's multiple comparisons test was used for the comparisons among more than two groups.
Further information on materials, cell culture, lentivirus preparation and infection, protein purification, APP and CHL1 processing assays are provided in Supplementary material.
Supplementary material
Supplementary material is available at Journal of Molecular Cell Biology online.
